Avidity Partners Management LP - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 138 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
Avidity Partners Management LP ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$11,120,084
-25.8%
8,298,570
-0.9%
0.45%
-14.3%
Q2 2023$14,982,479
-60.0%
8,370,100
-13.1%
0.52%
-58.0%
Q1 2023$37,475,914
+14.4%
9,633,9110.0%1.24%
+75.2%
Q4 2022$32,755,2979,633,9110.71%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Consonance Capital Management LP 4,767,078$80,993,0005.22%
Palo Alto Investors LP 4,663,324$79,230,0003.17%
DOHENY ASSET MANAGEMENT /CA 282,945$4,807,0002.61%
Private Capital Advisors, Inc. 416,900$7,083,0002.22%
Sandia Holdings, LLC 119,739$2,034,0000.91%
Virtus ETF Advisers LLC 44,986$764,0000.68%
Birchview Capital, LP 50,000$850,0000.58%
Schonfeld Strategic Advisors LLC 415,600$7,061,0000.38%
EMERALD ADVISERS, LLC 561,317$9,537,0000.36%
Kazazian Asset Management, LLC 20,672$351,0000.32%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders